Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Puma Biotechnology (PBYI)
Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Puma Biotech: Q2 Earnings Snapshot AP - Thu Aug 3, 4:17PM CDT

Puma Biotech: Q2 Earnings Snapshot

PBYI : 2.89 (-0.34%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer BayStreet.ca - Tue Jun 27, 7:33AM CDT

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 550.54 (+0.07%)
PBYI : 2.89 (-0.34%)
GILD : 75.01 (-0.35%)
IMGN : 14.77 (-1.07%)
BCTX : 5.42 (-6.07%)
BCT.TO : 7.39 (-5.26%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer BayStreet.ca - Thu May 25, 8:21AM CDT

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 550.54 (+0.07%)
PBYI : 2.89 (-0.34%)
GILD : 75.01 (-0.35%)
IMGN : 14.77 (-1.07%)
BCTX : 5.42 (-6.07%)
BCT.TO : 7.39 (-5.26%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today BayStreet.ca - Mon May 15, 8:55AM CDT

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 550.54 (+0.07%)
PBYI : 2.89 (-0.34%)
GILD : 75.01 (-0.35%)
IMGN : 14.77 (-1.07%)
BCTX : 5.42 (-6.07%)
BCT.TO : 7.39 (-5.26%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Fri May 5, 4:15PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 1, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 2.89 (-0.34%)
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y Zacks - Fri May 5, 11:45AM CDT

Puma Biotechnology (PBYI) earnings and sales beat estimates in Q1. Stock rises in after-hours.

PBYI : 2.89 (-0.34%)
RCUS : 19.72 (-3.24%)
ALLO : 3.65 (-1.88%)
OCUP : 3.87 (-0.51%)
Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates Zacks - Thu May 4, 5:15PM CDT

Puma Biotech (PBYI) delivered earnings and revenue surprises of 550% and 6.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PBYI : 2.89 (-0.34%)
LCTX : 1.1900 (-6.30%)
Puma Biotech: Q1 Earnings Snapshot AP - Thu May 4, 4:32PM CDT

Puma Biotech: Q1 Earnings Snapshot

PBYI : 2.89 (-0.34%)
Puma Biotechnology Reports First Quarter Financial Results Business Wire - Thu May 4, 3:04PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2023. Unless otherwise stated, all comparisons are for the first...

PBYI : 2.89 (-0.34%)
Intercept Pharmaceuticals (ICPT) Reports Q1 Loss, Lags Revenue Estimates Zacks - Thu Apr 27, 7:25AM CDT

Intercept (ICPT) delivered earnings and revenue surprises of -35.09% and 7.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ICPT : 10.48 (-2.96%)
PBYI : 2.89 (-0.34%)

Barchart Exclusives

Three Spinoff Companies That Are Seriously Undervalued Barchart - Sun Sep 24, 2:31PM CDT
Spinoffs are a great hunting ground for investment because they have the potential to generate higher returns than the broader market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot